Key result
Management of malignant pleural effusion due to angiosarcoma presents unique diagnostic and treatment challenges in a single patient case report.
Why the study?
Malignant pleural effusion due to angiosarcoma is a less commonly described entity and its management presents a unique challenge.
Case Report (n=1)
Highlights the diagnostic and therapeutic challenges of managing malignant pleural effusion secondary to angiosarcoma.
Alerts clinicians to rare angiosarcoma effusions; leaves open optimal management strategies pending larger studies.
Angiosarcoma is a rare and aggressive vascular malignancy that typically originates in the skin or soft tissue of the body. It is known to have a propensity for metastasis to the lung parenchyma in the form of pulmonary nodules and cavitary lesions; however, a less commonly described entity is in the form of a malignant pleural effusion. Management of a malignant pleural effusion due to angiosarcoma presents a unique challenge. This article describes the challenges faced during one patient's diagnostic and treatment course, and the anticipated future complications of his aggressive disease.
No takes yet. Share an insight, caveat, or question.
Meerschaert et al. (2023) conducted a case report in Malignant pleural effusion due to angiosarcoma (n=1). Diagnostic and treatment course was evaluated. Management of malignant pleural effusion due to angiosarcoma presents unique diagnostic and treatment challenges in a single patient case report.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: